Biotechnik

Two More NovaSeq™ X Plus: CeGaT Expands Sequencing Power

With four NovaSeq™ X Plus systems now in operation, we provide the high-throughput sequencing power required to deliver fast and precise results for large-scale projects. This investment underscores our commitment to integrating state-of-the-art technologies and ensuring that our laboratory remains at the forefront of sequencing innovation.

Trusted quality: certified to the highest standards
To fully leverage our expanded sequencing capacity, we uphold the highest quality standards in our laboratory. CeGaT‘s laboratory meets the highest international standards: It is IVDR compliant and accredited according to CAP/CLIA, DIN EN ISO 15189, and DIN EN ISO/IEC 17025. “Quality is at the core of everything we do,” emphasizes Dr. Ute Metzger, Head of Quality Management at CeGaT. “These certifications reflect our dedication to delivering the highest level of quality, reliability, and regulatory compliance across all sequencing processes.”

Precision in every step: automated laboratory workflows
A crucial step in generating high-quality sequencing data is the accurate and efficient preparation of samples. To ensure efficiency and reliability, we rely on automation. Our in-house team specializes in developing and optimizing automated laboratory workflows. This enables easy scalability and guarantees consistently high-quality, comparable results. A key component of this approach is our ten Hamilton Liquid Handling Stations, which automate and standardize pipetting processes. By ensuring precise and reproducible liquid handling, they minimize errors and increase throughput before samples proceed to sequencing.

Powerful sequencing platforms for every project size
The samples are sequenced on our advanced platforms, each delivering high data quality and supporting different project scales and applications. To meet diverse research needs, we offer a comprehensive product portfolio featuring the following platforms:

  • Four NovaSeq™ X Plus: Each machine generates up to 16 terabases of data in just 48 hours, ideal for large-scale projects.
  • Five NovaSeq™ 6000: A versatile platform suited for projects requiring high performance without the maximum sequencing volume.
  • Two Illumina MiSeq™: A compact system tailored for smaller, targeted projects.
  • One PacBio Revio and one Sequel® IIe: Both enable high-quality long-read sequencing.

Your partner for high-quality NGS solutions
“Our continuous investment in sequencing technology ensures that researchers and clinicians receive the highest-quality data to advance scientific and medical innovation,” says Dr. Dirk Biskup, Managing Director and Co-founder of CeGaT. “We provide NGS products ranging from, for example, genome, transcriptome, exome, and metagenome sequencing to TSO500 and 10x single-cell transcriptomics.”

We support you in choosing the right platform and application for your projects – contact us today.

Über die CeGaT GmbH

CeGaT GmbH, founded in Tübingen, Germany, in 2009, is a global provider of genetic analyses for a wide range of medical, research, and pharmaceutical applications.

The company combines the latest sequencing technology with its many years of medical expertise – dedicated to identifying the genetic cause of disease and supporting patient care. For research and the pharmaceutical industry, CeGaT offers a broad portfolio of sequencing services and tumor analyses. CeGaT generates the data basis for clinical studies and medical innovations, driving science forward with own findings. The owner-managed company stands for independence, an extensive personal customer service, and premium quality. CeGaT’s laboratory is accredited according to CAP/CLIA, DIN EN ISO 15189, and DIN EN ISO 17025 and thus meets the highest international standards. To keep the responsibility for the whole project, and to maintain the best results, CeGaT carries out all steps in-house and under scientific supervision.

Firmenkontakt und Herausgeber der Meldung:

CeGaT GmbH
Paul-Ehrlich-Str. 23
72076 Tübingen
Telefon: +49 7071 56544 260
http://www.cegat.com

Ansprechpartner:
Nora Zeller
Marketing & Communication
Telefon: +49 (7071) 56544-260
E-Mail: nora.zeller@cegat.de
Für die oben stehende Story ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel